Endo Axiom’s cutting-edge nanoparticle platform technology is set to revolutionise diabetes treatment.

Sector
Therapeutics
Origin
USYD, Sydney Local Health District
Key Milestone
STAGE
Incubated
Partnered In
2023
Founded by
Dr Nick Hunt, Prof. David Le Couteur, Prof. Victoria Cogger
"

  • "

  • "

  • "

  • "